Sildenafil Citrate Liposomes for Pulmonary Delivery by Ultrasonic Nebulization

[1]  M. Elphick,et al.  Factors to consider when selecting a nebulizer for a new inhaled drug product development program , 2015, Expert opinion on drug delivery.

[2]  P. Couvreur,et al.  Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. , 2000, International journal of antimicrobial agents.

[3]  A. S. Navarro,et al.  Albumin micro/nanoparticles entrapping liposomes for itraconazole green formulation , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  A. Elhissi.  Liposomes for Pulmonary Drug Delivery: The Role of Formulation and Inhalation Device Design. , 2017, Current pharmaceutical design.

[5]  H. Ghofrani,et al.  Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond , 2006, Nature Reviews Drug Discovery.

[6]  C. Goss,et al.  Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection , 2013, Thorax.

[7]  Wei Sun,et al.  Preparation of submicron liposomes exhibiting efficient entrapment of drugs by freeze-drying water-in-oil emulsions. , 2011, Chemistry and physics of lipids.

[8]  P. Smith,et al.  Safety of Sildenafil in Infants* , 2014, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[9]  D. Ivy,et al.  Pulmonary arterial hypertension: a comparison between children and adults , 2011, European Respiratory Journal.

[10]  Z. Zuo,et al.  Mechanistic analysis of pH-dependent solubility and trans-membrane permeability of amphoteric compounds: application to sildenafil. , 2008, International journal of pharmaceutics.

[11]  M. R. Mozafari,et al.  Liposomes: an overview of manufacturing techniques. , 2005, Cellular & molecular biology letters.

[12]  N. Nafee,et al.  Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor. , 2017, International journal of pharmaceutics.

[13]  Doaa H Hassan,et al.  Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate , 2017, Drug delivery.

[14]  T. Seki,et al.  Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Leslie Y Yeo,et al.  Ultrasonic nebulization platforms for pulmonary drug delivery , 2010, Expert opinion on drug delivery.

[16]  A. S. Navarro,et al.  Pulmonary versus Systemic Delivery of Antibiotics: Comparison of Vancomycin Dispositions in the Isolated Rat Lung , 2007, Antimicrobial Agents and Chemotherapy.

[17]  Dandan Han,et al.  An overview of liposome lyophilization and its future potential. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[18]  A. Elhissi,et al.  Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications , 2016, Medical Principles and Practice.

[19]  W. Seeger,et al.  Potential of the isolated lung technique for the examination of sildenafil absorption from lung-delivered poly(lactide-co-glycolide) microparticles. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[20]  L. Frumkin.  The Pharmacological Treatment of Pulmonary Arterial Hypertension , 2012, Pharmacological Reviews.

[21]  J. Corbin,et al.  Cyclic GMP Phosphodiesterase-5: Target of Sildenafil* , 1999, The Journal of Biological Chemistry.

[22]  M. Rouini,et al.  Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics* , 2016, Pharmaceutical development and technology.

[23]  W. Seeger,et al.  Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[24]  A. S. Navarro,et al.  Pharmaceutics, Drug Delivery and Pharmaceutical Technology Development and In Vitro Evaluation of a Novel Drug Delivery System (Albumin Microspheres Containing Liposomes) Applied to Vancomycin , 2016 .

[25]  G. Leitinger,et al.  Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  J. Bangham,et al.  The interaction of detergents with bilayer lipid membranes. , 1978, Biochimica et biophysica acta.

[27]  M. Moschos,et al.  Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction , 2016, Drug design, development and therapy.

[28]  W. Seeger,et al.  Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization. , 2012, International journal of pharmaceutics.

[29]  C. Tros de Ilarduya,et al.  Application of different methods to formulate PEG-liposomes of oxaliplatin: evaluation in vitro and in vivo. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  S. Büttgenbach,et al.  Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application. , 2014, International journal of pharmaceutics.

[31]  A. S. Navarro,et al.  Pulmonary disposition of vancomycin nebulized as lipid vesicles in rats , 2013, Journal of antibiotics (Tokyo. 1968).

[32]  T. Gana,et al.  Hepatic-Directed Vesicle Insulin: A Review of Formulation Development and Preclinical Evaluation , 2009, Journal of diabetes science and technology.

[33]  N. Chattipakorn,et al.  Effects of Kaempferia parviflora Wall. Ex. Baker and Sildenafil Citrate on cGMP Level, Cardiac Function, and Intracellular Ca2+ Regulation in Rat Hearts , 2012, Journal of cardiovascular pharmacology.

[34]  N. K. Jain,et al.  Micro- and nanocarrier-mediated lung targeting , 2010, Expert opinion on drug delivery.

[35]  R. Tulloh,et al.  Sildenafil in Infants and Children , 2017, Children.

[36]  W. Seeger,et al.  Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[37]  Wen Tan,et al.  Preparation of a Sustained-Release Nebulized Aerosol of R-terbutaline Hydrochloride Liposome and Evaluation of Its Anti-asthmatic Effects via Pulmonary Delivery in Guinea Pigs , 2017, AAPS PharmSciTech.

[38]  Jennifer S. Li,et al.  Pharmacokinetics of intravenous sildenafil in children with palliated single ventricle heart defects: effect of elevated hepatic pressures , 2015, Cardiology in the Young.

[39]  Jeong-Sook Park,et al.  Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method , 2013, International journal of nanomedicine.

[40]  Hideki Sakai,et al.  Preparation of liposomes using an improved supercritical reverse phase evaporation method. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[41]  V. Turjanmaa,et al.  Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. , 1999, International journal of pharmaceutics.